COMMUNITY

ÃÖ°íÀÇ ±â¼ú·Â°ú ÃÖ»óÀÇ Ç°Áú,
ÂøÇÑ °¡°ÝÀ¸·Î º¸´äÇÏ¿© µå¸®°Ú½À´Ï´Ù.

Ä¿¹Â´ÏƼ
Community

  • Ȩ
  • Ä¿¹Â´ÏƼ
  • ÇÁ·Î¸ð¼Ç

ÇÁ·Î¸ð¼Ç

ÇÑÁ¤±â°£ ¾Æ¹Ù¹ÙÀÌ¿À Á¦°øÇϴ Ưº°ÇÑ °¡°Ý
¹øÈ£ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏÀÚ Á¶È¸¼ö
481 [Abbaltis] Autoimmune material - July 21 abbabio 2022-07-21 18
480 [Abbaltis] Infectious disease material offer - July 21 abbabio 2022-07-21 13
479 [Cusabio] CLDN6, the "New Favorite" in Targeted Cancer Therapy after CLDN 18.2 abbabio 2022-07-21 20
478 [Abbaltis] NEW Product Line - Luteinising Hormone - July 20 abbabio 2022-07-20 4
477 [Abbaltis] Infectious offer - July 20 abbabio 2022-07-20 5
476 [Abbaltis] Allergy material available - July 20 abbabio 2022-07-20 12
475 [Cusabio] To explore key genes in "Cuprotosis", improving future treatment in Wi.. abbabio 2022-07-14 3
474 [Kerafast] From the Freezer: July 2022 Kerafast E-Newsletter abbabio 2022-07-14 7
473 [Abbaltis] Allergy material available abbabio 2022-07-11 7
472 [Cusabio] 193 Articles Updated Using ELISA, Protein, Antibody! Impact Factor Tot.. abbabio 2022-07-11 4